During the event, she was honored with the prestigious Disruptive Innovation Award, which recognizes the fastest-growing brands and acknowledges the founders, angel investors, crowd funders and early stage venture capital investors behind them.
The treatment illuminates tumor cells during surgery to improve quality of life, patient treatment and survival rates.
Novel tools from research on antivirals at Georgia State University are now making their way to the marketplace.
Georgia State startup company focused on immune response develops broad-spectrum immunotherapies for cancer treatment.
A nationwide surge in cases places the spotlight on efforts to treat and develop vaccines for respiratory viruses, including respiratory syncytial virus.
Georgia State University President Dr. M. Brian Blake highlighted his commitment to research and innovation during his recent investiture.
The researchers designed a single, universal influenza vaccine candidate that protects against diverse variants of both influenza A and B viruses in mice.
Georgia State researchers are teaming up with industry in new ways to help bring their innovative breakthroughs to the marketplace.
The newly designed artificial vision device could have far-reaching applications for the fields of medicine, artificial intelligence, and microrobotics.
Drugs for inflammatory bowel disease are ineffective and have serious side effects. Professor Didier Merlin is developing a better treatment approach using nanotechnology.
